Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants (scientific article)

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design

Q26801759

Antibody responses to envelope glycoproteins in HIV-1 infection

Q26991572

HIV-1 neutralizing antibodies: understanding nature's pathways

Q27000480

Multiple alignment using hidden Markov models

Q52361706

Progress in HIV-1 vaccine development

Q56600657

Adaptation to Human Populations Is Revealed by Within-Host Polymorphisms in HIV-1 and Hepatitis C Virus

Q27478199

Viral Sequence Evolution in Acute Hepatitis C Virus Infection

Q27484985

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Q27644501

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Q27644515

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

Q27663293

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Q27670829

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

Q27671696

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Q27675879

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

Q27678306

Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains

Q27684503

Progress in HIV-1 vaccine development.

Q27693849

New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0

Q27860476

WebLogo: A Sequence Logo Generator

Q27860646

A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood

Q27861000

Not so different after all: a comparison of methods for detecting amino acid sites under selection

Q28306719

Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing

Q28482493

Loss and recovery of genetic diversity in adapting populations of HIV

Q28539052

Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies

Q28602877

APE: Analyses of Phylogenetics and Evolution in R language

Q29546513

Antibody neutralization and escape by HIV-1

Q29547345

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Q29547347

A new method for calculating evolutionary substitution rates

Q29615058

Broad neutralization coverage of HIV by multiple highly potent antibodies

Q29615361

Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology

Q29617583

Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene

Q29617599

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

Q29618603

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Q29619510

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

Q29619511

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

Q29619980

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection

Q30469621

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing

Q36540055

Emergence of stable polymorphisms driven by evolutionary games between mutants

Q36752893

Vaccines: correlates of vaccine-induced immunity

Q37193062

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

Q37273158

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

Q37273195

The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility.

Q37667754

The role of antibodies in HIV vaccines

Q37700725

Variable and conserved neutralization antigens of human immunodeficiency virus

Q38891686

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation

Q38988188

DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination

Q39509643

Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection.

Q40016358

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection

Q40341996

Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors

Q41818598

Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies

Q42170932

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

Q45771143

Retrieval and on-the-fly alignment of sequence fragments from the HIV database.

Q48679004

Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues

Q30644992

Adaptation to different human populations by HIV-1 revealed by codon-based analyses

Q33247450

HIV-specific probabilistic models of protein evolution

Q33286820

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

Q33592278

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Q33647300

Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing

Q33680395

Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

Q33702217

Estimating time since infection in early homogeneous HIV-1 samples using a poisson model

Q33727328

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus

Q33955998

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies

Q34114798

B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study

Q34273373

Detecting individual sites subject to episodic diversifying selection

Q34341393

Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.

Q34594513

Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1

Q34594701

Amphiphilic block copolymers enhance the cellular uptake of DNA molecules through a facilitated plasma membrane transport

Q34609270

Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks.

Q34806845

A multiple-alignment based primer design algorithm for genetically highly variable DNA targets

Q34960846

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

Q34962766

Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies

Q34982715

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

Q35034268

HIV-1-specific antibody responses during acute and chronic HIV-1 infection

Q35096836

Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa

Q35115540

Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

Q35142291

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection

Q35274776

The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations

Q35377813

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

Q35382871

Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape

Q36000736

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses

Q36053810

Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially

Q36249053

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

Q36388754

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

Q36414891

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection

Q36444787

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape

Q36497283

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

page(s)

5443-5475

P577

publication date

2015-10-21

P1433

published in

Viruses

Q7935305

P1476

title

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

P478

volume

Reverse relations

cites work (P2860)

Q36337888	Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.
Q52595348	Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak.
Q39108751	Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development
Q47108789	Antigenic Variation and Immune Escape in the MTBC.
Q57796335	Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
Q52578356	HIV Resistance Prediction to Reverse Transcriptase Inhibitors: Focus on Open Data.
Q34527469	HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.
Q47549195	Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations
Q27644415	Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
Q47218587	Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.
Q39108740	Polyvalent vaccine approaches to combat HIV-1 diversity
Q59351843	Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Q30490942	Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.
Q57091049	Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Q40290521	Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.
Q64090748	The evolution of a super-swarm of foot-and-mouth disease virus in cattle